当前位置: X-MOL 学术Autophagy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Intestinal antiviral signaling is controlled by autophagy gene Epg5 independent of the microbiota
Autophagy ( IF 14.6 ) Pub Date : 2021-09-14 , DOI: 10.1080/15548627.2021.1968607
Sanghyun Lee 1 , Gowri Kalugotla 1 , Harshad Ingle 1 , Rachel Rodgers 1, 2 , Chunyan Wu 3 , Yating Wang 4 , Yuhao Li 1 , Xia Yang 3 , Jin Zhang 3 , Nicolette R Borella 1 , Hongju Deng 1 , Lindsay Droit 5 , Ryan Hill 1 , Stefan T Peterson 1 , Chandni Desai 5 , Dylan Lawrence 1 , Qun Lu 3 , Megan T Baldridge 1, 4
Affiliation  

ABSTRACT

Mutations in the macroautophagy/autophagy gene EPG5 are responsible for Vici syndrome, a human genetic disease characterized by combined immunodeficiency. Previously, we found that epg5−/- mice exhibit hyperinflammation in the lungs mediated by IL1B/IL-1β and TNF/TNFα, resulting in resistance to influenza. Here, we find that disruption of Epg5 results in protection against multiple enteric viruses including norovirus and rotavirus. Gene expression analysis reveals IFNL/IFN-λ responsive genes as a key alteration. Further, mice lacking Epg5 exhibit substantial alterations of the intestinal microbiota. Surprisingly, germ-free mouse studies indicate Epg5-associated inflammation of both the intestine and lung is microbiota-independent. Genetic studies support IFNL signaling as the primary mediator of resistance to enteric viruses, but not of microbial dysbiosis, in epg5−/- mice. This study unveils an important role, unexpectedly independent of the microbiota, for autophagy gene Epg5 in host organism protection by modulating intestinal IFNL responses.

Abbreviations: CTNNB1: catenin (cadherin associated protein), beta 1; DAPI: 4′,6-diamidino-2-phenylindole; EPG5: ectopic P-granules autophagy protein 5 homolog (C. elegans); FT: fecal transplant; IFI44: interferon-induced protein 44; IFIT1: interferon-induced protein with tetratricopeptide repeats 1; IFNG/IFN-γ: interferon gamma; IFNL/IFN-λ: interferon lambda; IFNLR1: interferon lambda receptor 1; IL1B/IL-1β: interleukin 1 beta; ISG: interferon stimulated gene; GF: germ-free; LEfSe: linear discriminant analysis effect size; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MNoV: murine norovirus; MX2: MX dynamin-like GTPase 2; OAS1A: 2’-5’ oligoadenylate synthetase 1A; RV: rotavirus; SPF: specific-pathogen free; SQSTM1/p62: sequestosome 1; STAT1: signal transducer and activator of transcription 1; STING1: stimulator of interferon response cGAMP interactor 1; TBK1: TANK-binding kinase 1; TNF/TNFα: tumor necrosis factor



中文翻译:

肠道抗病毒信号由自噬基因 Epg5 控制,与微生物群无关

摘要

巨自噬/自噬基因EPG5的突变导致 Vici 综合征,这是一种以联合免疫缺陷为特征的人类遗传病。以前,我们发现epg5 -/-小鼠在 IL1B/IL-1β 和 TNF/TNFα 介导的肺部表现出过度炎症,导致对流感的抵抗力。在这里,我们发现Epg5的破坏导致对包括诺如病毒和轮状病毒在内的多种肠道病毒的保护。基因表达分析揭示了 IFNL/IFN-λ 反应基因是一个关键的改变。此外,缺乏Epg5的小鼠表现出肠道微生物群的显着改变。令人惊讶的是,无菌小鼠研究表明Epg5-肠道和肺部的相关炎症与微生物群无关。遗传学研究支持 IFNL 信号作为epg5 -/-小鼠肠道病毒抗性的主要介质,而不是微生物菌群失调的主要介质。这项研究揭示了自噬基因Epg5通过调节肠道 IFNL 反应在宿主生物保护中的重要作用,出人意料地独立于微生物群。

缩写:CTNNB1:连环蛋白(钙粘蛋白相关蛋白),β 1;DAPI:4',6-二脒基-2-苯基吲哚;EPG5:异位 P 颗粒自噬蛋白 5 同系物(线虫);FT:粪便移植;IFI44:干扰素诱导蛋白 44;IFIT1:干扰素诱导蛋白与四肽重复序列 1;IFNG/IFN-γ:干扰素γ;IFNL/IFN-λ:干扰素λ;IFNLR1:干扰素λ受体1;IL1B/IL-1β:白细胞介素 1 β;ISG:干扰素刺激基因;GF:无菌;LEfSe:线性判别分析效应量;MAP1LC3/LC3:微管相关蛋白 1 轻链 3;MNoV:小鼠诺如病毒;MX2:MX 动力蛋白样 GTPase 2;OAS1A:2'-5'寡聚腺苷酸合成酶 1A;RV:轮状病毒;SPF:无特定病原体;SQSTM1/p62:螯合体 1;STAT1:信号转导和转录激活因子 1;STING1:干扰素反应刺激物 cGAMP 相互作用物 1;TBK1:TANK 结合激酶 1;TNF/TNFα:肿瘤坏死因子

更新日期:2021-09-14
down
wechat
bug